Nektar Therapeutics
NKTR
$1.32
Share price
0.00%
Change (1 day)
76.00%
Change (1 year)
Categories
Nektar Therapeutics (NKTR) - Total debt
Total debt on the balance sheet as of December 2023 : $0.11 B
According to Nektar Therapeutics 's latest financial reports the company's total debt is $0.11 B. A company’s total debt is the sum of all current and non-current debts.
Nektar Therapeutics - Total debt on balance sheet (from 2001 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $0.11 B | -10.43% |
| 2022-12-31 | $0.13 B | -8.16% |
| 2021-12-31 | $0.14 B | -4.73% |
| 2020-12-31 | $0.15 B | -63.18% |
| 2019-12-31 | $0.40 B | 65.27% |
| 2018-12-31 | $0.24 B | 0.71% |
| 2017-12-31 | $0.24 B | 0.72% |
| 2016-12-31 | $0.24 B | -1.64% |
| 2015-12-31 | $0.24 B | 85.2% |
| 2014-12-31 | $0.13 B | -2.15% |
| 2013-12-31 | $0.13 B | -0.02% |
| 2012-12-31 | $0.13 B | -40.49% |
| 2011-12-31 | $0.22 B | -1.05% |
| 2010-12-31 | $0.23 B | -0.76% |
| 2009-12-31 | $0.23 B | -0.66% |
| 2008-12-31 | $0.23 B | -30.1% |
| 2007-12-31 | $0.33 B | -23.16% |
| 2006-12-31 | $0.43 B | -0.07% |
| 2005-12-31 | $0.43 B | 120.24% |
| 2004-12-31 | $0.19 B | -49.39% |
| 2003-12-31 | $0.39 B | 18.46% |
| 2002-12-31 | $0.33 B | 0.05% |
| 2001-12-31 | $0.33 B |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $29.33 B | 24,804.90% | 🇺🇸 USA |
 Pfizer PFE | $70.84 B | 60,052.32% | 🇺🇸 USA |
 Amgen AMGN | $64.61 B | 54,760.92% | 🇺🇸 USA |
 Baxter BAX | $14.36 B | 12,096.03% | 🇺🇸 USA |
 Merck MRK | $35.05 B | 29,664.13% | 🇺🇸 USA |
 AstraZeneca AZN | $34.55 B | 29,236.20% | 🇬🇧 UK |
 Richardson Electronics RELL | $3.12 M | -97.35% | 🇺🇸 USA |
 Alkermes ALKS | $0.37 B | 216.01% | 🇮🇪 Ireland |